BioSTL builds regional capacity and fosters collaborative efforts to advance innovation,
BioSTL has raised $2.0M in total funding. The most recent round was Grant. The last funding was announced in January 2023.
BioSTL's investors include Bayer, JP Morgan Chase, US Department of Commerce, Economic Development Administation, Missouri Department of Economic Development.
BioSTL is headquartered in St Louis, United States.
BioSTL builds regional capacity and fosters collaborative efforts to advance innovation,
BioSTL is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioSTL — Funding & Investors." VCBacked, January 24, 2023, https://www.vcbacked.co/company/biostl. Accessed September 15, 2026.
VCBacked. (2023). BioSTL — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/biostl
{{cite web |title=BioSTL — Funding & Investors |url=https://www.vcbacked.co/company/biostl |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated